Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
AFFIRM: Risankizumab (Skyrizi) Subcutaneous Induction Achieves Primary Endpoints in Crohn’s Disease

AFFIRM: Risankizumab (Skyrizi) Subcutaneous Induction Achieves Primary Endpoints in Crohn’s Disease

Indeterminate Consultant Live
Owner: Mike Hennessy Jr.
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead

Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead

Vizient Awards Cresilon an Innovative Technology Contract for Anti-Bleeding Gel

Vizient Awards Cresilon an Innovative Technology Contract for Anti-Bleeding Gel

Garfield Re-2 discusses rising insurance rates driven by medical costs

Garfield Re-2 discusses rising insurance rates driven by medical costs

AI 411: February 2026

AI 411: February 2026

ADVANCE OUTCOMES: Ralinepag Outperforms Placebo in Slowing Disease Progression in PAH

ADVANCE OUTCOMES: Ralinepag Outperforms Placebo in Slowing Disease Progression in PAH

Dietary Protein as a Modifiable Risk Factor in Liver Cancer, With Wei-Xing Zong, PhD

Dietary Protein as a Modifiable Risk Factor in Liver Cancer, With Wei-Xing Zong, PhD

Endometriosis: patients now waiting nearly a decade to get a diagnosis for 'debilitating' condition

Endometriosis: patients now waiting nearly a decade to get a diagnosis for 'debilitating' condition

Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead

Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead

Vizient Awards Cresilon an Innovative Technology Contract for Anti-Bleeding Gel

Vizient Awards Cresilon an Innovative Technology Contract for Anti-Bleeding Gel

Garfield Re-2 discusses rising insurance rates driven by medical costs

Garfield Re-2 discusses rising insurance rates driven by medical costs

AI 411: February 2026

AI 411: February 2026

ADVANCE OUTCOMES: Ralinepag Outperforms Placebo in Slowing Disease Progression in PAH

ADVANCE OUTCOMES: Ralinepag Outperforms Placebo in Slowing Disease Progression in PAH

Dietary Protein as a Modifiable Risk Factor in Liver Cancer, With Wei-Xing Zong, PhD

Dietary Protein as a Modifiable Risk Factor in Liver Cancer, With Wei-Xing Zong, PhD

Endometriosis: patients now waiting nearly a decade to get a diagnosis for 'debilitating' condition

Endometriosis: patients now waiting nearly a decade to get a diagnosis for 'debilitating' condition

AFFIRM: Risankizumab (Skyrizi) Subcutaneous Induction Achieves Primary Endpoints in Crohn’s Disease

AFFIRM: Risankizumab (Skyrizi) Subcutaneous Induction Achieves Primary Endpoints in Crohn’s Disease

Show More

Video Stories

YouTube video thumbnail: Israeli Hospital Moves Patients Underground as Iran Retaliates
Play
Israeli Hospital Moves Patients Underground as Iran Retaliates
YouTube video thumbnail: How Both Criminals and Governments Turn Your Medical Data Into Oppressive Tools
Play
How Both Criminals and Governments Turn Your Medical Data Into Oppressive Tools
YouTube video thumbnail:  Zambia’s Toxic Legacy
Play
Zambia’s Toxic Legacy
YouTube video thumbnail: What Is Biocomputing?
Play
What Is Biocomputing?

Video Title

Press Releases

Voting in the 2026 RCP elections is now open

Voting in the 2026 RCP elections is now open

RCP issues statement on conflict in the Middle East

RCP issues statement on conflict in the Middle East

RCP issues statement on conflict in the Middle East

RCP issues statement on conflict in the Middle East

Voting in the 2026 RCP elections is now open

Voting in the 2026 RCP elections is now open

RCP issues statement on conflict in the Middle East

RCP issues statement on conflict in the Middle East

RCP issues statement on conflict in the Middle East

RCP issues statement on conflict in the Middle East

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions